{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:02:39Z","timestamp":1792202559590,"version":"4.4.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Differentiation"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.diff.2024.100793","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T11:44:24Z","timestamp":1719661464000},"page":"100793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Fibroblast growth factor 21"],"prefix":"10.1016","volume":"139","author":[{"given":"Guillaume J.","family":"Trusz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diff.2024.100793_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1150222","article-title":"Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho","volume":"14","author":"Aaldijk","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"19","key":"10.1016\/j.diff.2024.100793_bib2","doi-asserted-by":"crossref","first-page":"14078","DOI":"10.1074\/jbc.C110.107375","article-title":"Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner","volume":"285","author":"Adams","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.diff.2024.100793_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.003","article-title":"Molecular elements in FGF19 and FGF21 defining KLB\/FGFR activity and specificity","volume":"13","author":"Agrawal","year":"2018","journal-title":"Mol. Metabol."},{"issue":"5","key":"10.1016\/j.diff.2024.100793_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nrc.2017.8","article-title":"Advances and challenges in targeting FGFR signalling in cancer","volume":"17","author":"Babina","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.diff.2024.100793_bib5","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/en.2009-0532","article-title":"Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis","volume":"150","author":"Badman","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.diff.2024.100793_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.omtn.2022.04.010","article-title":"Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice","volume":"28","author":"Bartesaghi","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"46","key":"10.1016\/j.diff.2024.100793_bib7","doi-asserted-by":"crossref","first-page":"28992","DOI":"10.1073\/pnas.2012073117","article-title":"Antibody-mediated activation of the FGFR1\/Klotho\u03b2 complex corrects metabolic dysfunction and alters food preference in obese humans","volume":"117","author":"Baruch","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.diff.2024.100793_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajpath.2021.10.017","article-title":"ZFP36L1 regulates Fgf21 mRNA turnover and modulates alcoholic hepatic steatosis and inflammation in mice","volume":"192","author":"Bathula","year":"2022","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.diff.2024.100793_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004168","article-title":"Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the fibroblast growth factor 21 locus","volume":"8","author":"Bayoumi","year":"2021","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.diff.2024.100793_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015958","article-title":"Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology","volume":"5","author":"Belov","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"10","key":"10.1016\/j.diff.2024.100793_bib12","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.3168\/jds.S0022-0302(04)73446-3","article-title":"Invited review: pathology, etiology, prevention, and treatment of fatty liver in dairy cows","volume":"87","author":"Bobe","year":"2004","journal-title":"J. Dairy Sci."},{"issue":"14","key":"10.1016\/j.diff.2024.100793_bib13","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3390\/cells11142251","article-title":"Maternal fibroblast growth factor 21 levels decrease during early pregnancy in normotensive pregnant women but are higher in preeclamptic women-A longitudinal study","volume":"11","author":"Buell-Acosta","year":"2022","journal-title":"Cells"},{"issue":"1 Suppl. l","key":"10.1016\/j.diff.2024.100793_bib14","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.diff.2024.100793_bib15","first-page":"573","article-title":"Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon","volume":"73","author":"Byrne","year":"2024","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.diff.2024.100793_bib16","doi-asserted-by":"crossref","first-page":"11597","DOI":"10.3168\/jds.2019-16696","article-title":"Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. II. Pharmacokinetics, whole-animal performance, and lipid metabolism","volume":"102","author":"Caixeta","year":"2019","journal-title":"J. Dairy Sci."},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/oby.22344","article-title":"Pegbelfermin (BMS-986036), PEGylated FGF21, in patients with obesity and type 2 diabetes: results from a randomized phase 2 study","volume":"27","author":"Charles","year":"2019","journal-title":"Obesity"},{"issue":"10","key":"10.1016\/j.diff.2024.100793_bib18","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2337\/db11-0112","article-title":"Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice","volume":"60","author":"Chartoumpekis","year":"2011","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/dom.13560","article-title":"FGF21 decreases food intake and body weight in obese G\u00f6ttingen minipigs","volume":"21","author":"Christoffersen","year":"2019","journal-title":"Diabetes Obes. Metabol."},{"issue":"9","key":"10.1016\/j.diff.2024.100793_bib20","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/hmg\/ddt032","article-title":"Novel locus including FGF21 is associated with dietary macronutrient intake","volume":"22","author":"Chu","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.diff.2024.100793_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tem.2024.02.001","article-title":"Current status and future perspectives of FGF21 analogues in clinical trials","volume":"35","author":"Chui","year":"2024","journal-title":"Trends Endocrinol. Metabol.: TEM (Trends Endocrinol. Metab.)"},{"issue":"12","key":"10.1016\/j.diff.2024.100793_bib22","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.diff.2024.100793_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fphys.2019.00037","article-title":"Fibroblast growth factor 21 and browning of white adipose tissue","volume":"10","author":"Cuevas-Ramos","year":"2019","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib24","doi-asserted-by":"crossref","first-page":"R290","DOI":"10.1152\/ajpregu.00554.2013","article-title":"Hepatic FGF21 production is increased in late pregnancy in the mouse","volume":"307","author":"Cui","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"2","key":"10.1016\/j.diff.2024.100793_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/uog.17360","article-title":"Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis","volume":"49","author":"de Haas","year":"2017","journal-title":"Ultrasound Obstet. Gynecol. : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/BJ20111748","article-title":"Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation","volume":"443","author":"De Sousa-Coelho","year":"2012","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","article-title":"\u03b2Klotho is required for fibroblast growth factor 21 effects on growth and metabolism","volume":"16","author":"Ding","year":"2012","journal-title":"Cell Metabol."},{"issue":"2","key":"10.1016\/j.diff.2024.100793_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13105-019-00675-7","article-title":"FGF19 subfamily members: FGF19 and FGF21","volume":"75","author":"Dolegowska","year":"2019","journal-title":"J. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2337\/db14-0158","article-title":"Ligand-activated PPAR\u03b1-dependent DNA demethylation regulates the fatty acid \u03b2-oxidation genes in the postnatal liver","volume":"64","author":"Ehara","year":"2015","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.diff.2024.100793_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI67353","article-title":"Interplay between FGF21 and insulin action in the liver regulates metabolism","volume":"124","author":"Emanuelli","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.diff.2024.100793_bib32","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.diff.2024.100793_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu. Rev. Physiol."},{"issue":"162","key":"10.1016\/j.diff.2024.100793_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004690","article-title":"Treating diabetes and obesity with an FGF21-mimetic antibody activating the \u03b2Klotho\/FGFR1c receptor complex","volume":"4","author":"Foltz","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.1016\/j.diff.2024.100793_bib35","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.diff.2024.100793_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.molcel.2006.01.022","article-title":"Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction","volume":"21","author":"Furdui","year":"2006","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.diff.2024.100793_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/gtc.12186","article-title":"Nrf2 induces fibroblast growth factor 21 in diabetic mice","volume":"19","author":"Furusawa","year":"2014","journal-title":"Gene Cell. : devoted to molecular & cellular mechanisms"},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31506-2","article-title":"Gene expression profiling during hibernation in the European hamster","volume":"8","author":"Gautier","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.diff.2024.100793_bib39","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.31843","article-title":"Saroglitazar, a PPAR-\u03b1\/\u03b3 agonist, for treatment of nafld: a randomized controlled double-blind phase 2 trial","volume":"74","author":"Gawrieh","year":"2021","journal-title":"Hepatology (Baltimore, Md"},{"issue":"11","key":"10.1016\/j.diff.2024.100793_bib40","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.diff.2024.100793_bib41","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.3390\/ijms24087556","article-title":"Exploring the structural and functional diversity among fgf signals: a comparative study of human, mouse, and Xenopus fgf ligands in embryonic development and cancer pathogenesis","volume":"24","author":"Goutam","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.diff.2024.100793_bib42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.recesp.2011.07.009","article-title":"El coraz\u00f3n durante el embarazo [The heart during pregnancy]","volume":"64","author":"Hall","year":"2011","journal-title":"Rev. Esp. Cardiol."},{"issue":"7","key":"10.1016\/j.diff.2024.100793_bib43","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41591-021-01425-3","article-title":"Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial","volume":"27","author":"Harrison","year":"2021","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.diff.2024.100793_bib44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diff.2024.100793_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114729","article-title":"Analytical validation of a novel panel of biomarkers for a test for preeclampsia","volume":"214","author":"Hendershot","year":"2022","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.diff.2024.100793_bib46","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metabol."},{"issue":"12","key":"10.1016\/j.diff.2024.100793_bib47","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","article-title":"The fasting polypeptide FGF21 can enter brain from blood","volume":"28","author":"Hsuchou","year":"2007","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.diff.2024.100793_bib48","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.cmet.2024.03.013","article-title":"Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells","volume":"36","author":"Hu","year":"2024","journal-title":"Cell Metabol."},{"issue":"2","key":"10.1016\/j.diff.2024.100793_bib49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.celrep.2017.09.065","article-title":"A specific ChREBP and PPAR\u03b1 cross-talk is required for the glucose-mediated FGF21 response","volume":"21","author":"Iroz","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","article-title":"Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease","volume":"342","author":"Itoh","year":"2010","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jog.14534","article-title":"Serum fibroblast growth factor 21 level is increased in pre-eclampsia patients: association with blood pressure and lipid profile","volume":"47","author":"Jiang","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"8","key":"10.1016\/j.diff.2024.100793_bib52","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.diff.2024.100793_bib53","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cmet.2022.03.005","article-title":"Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure","volume":"34","author":"Katsumura","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.diff.2024.100793_bib54","series-title":"Resmetirom: First Approval. Drugs","author":"Keam","year":"2024"},{"issue":"8","key":"10.1016\/j.diff.2024.100793_bib55","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EC-20-0152","article-title":"FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation","volume":"9","author":"Keinicke","year":"2020","journal-title":"Endocrine connections"},{"issue":"6","key":"10.1016\/j.diff.2024.100793_bib56","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058575","article-title":"Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319","volume":"8","author":"Kharitonenkov","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.diff.2024.100793_bib58","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/ani12070939","article-title":"FGF21 reduces lipid accumulation in bovine hepatocytes by enhancing lipid oxidation and reducing lipogenesis via AMPK signaling","volume":"12","author":"Kong","year":"2022","journal-title":"Animals : an open access journal from MDPI"},{"issue":"9","key":"10.1016\/j.diff.2024.100793_bib59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4254\/wjh.v5.i9.470","article-title":"Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease","volume":"5","author":"Kostapanos","year":"2013","journal-title":"World J. Hepatol."},{"issue":"11","key":"10.1016\/j.diff.2024.100793_bib60","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1007\/s00125-017-4389-x","article-title":"FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes","volume":"60","author":"Laeger","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.diff.2024.100793_bib61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nri1590","article-title":"The zebrafish: a new model of T-cell and thymic development","volume":"5","author":"Langenau","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.diff.2024.100793_bib62","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/dvdy.21913","article-title":"Temporal and spatial expression of FGF ligands and receptors during Xenopus development","volume":"238","author":"Lea","year":"2009","journal-title":"Dev. Dynam. : an official publication of the American Association of Anatomists"},{"issue":"7689","key":"10.1016\/j.diff.2024.100793_bib63","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature25010","article-title":"Structures of \u03b2-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling","volume":"553","author":"Lee","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.diff.2024.100793_bib64","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83075","article-title":"FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis","volume":"12","author":"Liu","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.diff.2024.100793_bib65","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH","author":"Loomba","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1677\/JME-09-0107","article-title":"Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors","volume":"44","author":"Lu","year":"2010","journal-title":"J. Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.diff.2024.100793_bib67","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","article-title":"PPARalpha is a key regulator of hepatic FGF21","volume":"360","author":"Lund\u00e5sen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.diff.2024.100793_bib68","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/db14-0595","article-title":"Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding","volume":"63","author":"Markan","year":"2014","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.diff.2024.100793_bib69","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/09168451.2015.1135045","article-title":"Fibroblast growth factor 21 induction by activating transcription factor 4 is regulated through three amino acid response elements in its promoter region","volume":"80","author":"Maruyama","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"38","key":"10.1016\/j.diff.2024.100793_bib70","doi-asserted-by":"crossref","first-page":"14678","DOI":"10.1074\/jbc.RA118.004343","article-title":"Agonistic \u03b2-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions","volume":"293","author":"Min","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.celrep.2016.08.086","article-title":"mTORC1 is a major regulatory node in the FGF21 signaling network in adipocytes","volume":"17","author":"Minard","year":"2016","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.diff.2024.100793_bib72","doi-asserted-by":"crossref","first-page":"19997","DOI":"10.1074\/jbc.M111.325670","article-title":"Dynamics and Distribution of Klotho\u03b2 (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex","volume":"287","author":"Ming","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib73","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41598-017-00349-8","article-title":"Fgf21 regulates T-cell development in the neonatal and juvenile thymus","volume":"7","author":"Nakayama","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053574","article-title":"Metabolic hormone FGF21 is induced in ground squirrels during hibernation but its overexpression is not sufficient to cause torpor","volume":"8","author":"Nelson","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib76","first-page":"215","article-title":"The Fibroblast Growth Factor signaling pathway. Wiley interdisciplinary reviews","volume":"4","author":"Ornitz","year":"2015","journal-title":"Dev. Biol."},{"key":"10.1016\/j.diff.2024.100793_bib77","article-title":"Evolution of the FGF gene family","volume":"2012","author":"Oulion","year":"2012","journal-title":"Int. J. Evol. Biol."},{"issue":"9","key":"10.1016\/j.diff.2024.100793_bib78","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nm.3250","article-title":"FGF21 contributes to neuroendocrine control of female reproduction","volume":"19","author":"Owen","year":"2013","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.diff.2024.100793_bib79","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep4.1558","article-title":"The selective peroxisome proliferator-activated receptor gamma modulator CHS-131 improves liver histopathology and metabolism in a mouse model of obesity and nonalcoholic steatohepatitis","volume":"4","author":"Perakakis","year":"2020","journal-title":"Hepatology communications"},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.diff.2024.100793_bib81","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.diff.2024.100793_bib82","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1\u20133","key":"10.1016\/j.diff.2024.100793_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.04.051","article-title":"Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome","volume":"662","author":"Sasaki","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib84","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1038\/s41598-020-64902-8","article-title":"Pemafibrate, a selective PPAR\u03b1 modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content","volume":"10","author":"Sasaki","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.diff.2024.100793_bib85","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/er.2017-00016","article-title":"Fibroblast growth factor 21-metabolic role in mice and men","volume":"38","author":"Staiger","year":"2017","journal-title":"Endocr. Rev."},{"issue":"15","key":"10.1016\/j.diff.2024.100793_bib86","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.7150\/ijbs.76924","article-title":"Hepatic FGF21: its emerging role in inter-organ crosstalk and cancers","volume":"18","author":"Sui","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib87","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.diff.2024.100793_bib88","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/me.2007-0313","article-title":"betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c","volume":"22","author":"Suzuki","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib89","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metabol."},{"issue":"6","key":"10.1016\/j.diff.2024.100793_bib90","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3945\/ajcn.112.052183","article-title":"Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake","volume":"97","author":"Tanaka","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"47","key":"10.1016\/j.diff.2024.100793_bib91","doi-asserted-by":"crossref","first-page":"36401","DOI":"10.1074\/jbc.M110.172866","article-title":"Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding","volume":"285","author":"Tong","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.diff.2024.100793_bib92","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1074\/jbc.M112.433482","article-title":"Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein","volume":"288","author":"Tong","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2018.04.048","article-title":"Acute cardiac effects of severe pre-eclampsia","volume":"72","author":"Vaught","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.diff.2024.100793_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090172","article-title":"Molecular characterization and mapping of Fgf21 gene in a foodfish species asian seabass","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.diff.2024.100793_bib95","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor \u03b3","volume":"109","author":"Wei","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.diff.2024.100793_bib96","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.tem.2017.07.003","article-title":"Surviving stress: modulation of ATF4-mediated stress responses in normal and malignant cells","volume":"28","author":"Wortel","year":"2017","journal-title":"Trends Endocrinol. Metabol.: TEM (Trends Endocrinol. Metab.)"},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib97","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.diff.2024.100793_bib98","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.embor.7400685","article-title":"Fgf21 is essential for haematopoiesis in zebrafish","volume":"7","author":"Yamauchi","year":"2006","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.diff.2024.100793_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033870","article-title":"Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.diff.2024.100793_bib100","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1073\/pnas.1514511113","article-title":"Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution","volume":"113","author":"Youm","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.diff.2024.100793_bib101","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41467-018-03038-w","article-title":"Epigenetic modulation of Fgf21 in the perinatal mouse liver ameliorates diet-induced obesity in adulthood","volume":"9","author":"Yuan","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.diff.2024.100793_bib102","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1073\/pnas.88.8.3446","article-title":"Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta","volume":"88","author":"Zhang","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.diff.2024.100793_bib103","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00065","article-title":"The starvation hormone, fibroblast growth factor-21, extends lifespan in mice","volume":"1","author":"Zhang","year":"2012","journal-title":"Elife"}],"container-title":["Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301468124000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301468124000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T01:25:10Z","timestamp":1726017910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301468124000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":103,"alternative-id":["S0301468124000495"],"URL":"https:\/\/doi.org\/10.1016\/j.diff.2024.100793","relation":{},"ISSN":["0301-4681"],"issn-type":[{"value":"0301-4681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 21","name":"articletitle","label":"Article Title"},{"value":"Differentiation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diff.2024.100793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Differentiation. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100793"}}